-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Alzheimer's disease (AD) is a progressive neurological disease characterized by impaired learning and memory functions, resulting in cognitive dysfunction
.
The hippocampus volume of AD patients is reduced, especially the hippocampal CA1 area is one of the most severely damaged areas, which can be used as an auxiliary examination area to improve the accuracy of AD diagnosis
.
Research result
The cognitive impairment of APPS1/PS1 mice at 6/8 months of age1.
2.
3.
References Le Xu, Yiying Zhou, Linbo Hu, Hongde Jiang, Yibei Dong, Haowei Shen, Zhongze Lou, Siyu Yang, Yunxin Ji, Liemin Ruan and Xiaoqin Zhang, Deficits in N-Methyl-D-Aspartate Receptor Function and Synaptic Plasticity in Hippocampal CA1 in APP/PS1 Mouse Model of Alzheimer's Disease, Front.
Aging Neurosci.
Leave a message here
.
The hippocampus volume of AD patients is reduced, especially the hippocampal CA1 area is one of the most severely damaged areas, which can be used as an auxiliary examination area to improve the accuracy of AD diagnosis
.
Research result
1.
The cognitive impairment of APPS1/PS1 mice at 6/8 months of age1.
2.
3.
References Le Xu, Yiying Zhou, Linbo Hu, Hongde Jiang, Yibei Dong, Haowei Shen, Zhongze Lou, Siyu Yang, Yunxin Ji, Liemin Ruan and Xiaoqin Zhang, Deficits in N-Methyl-D-Aspartate Receptor Function and Synaptic Plasticity in Hippocampal CA1 in APP/PS1 Mouse Model of Alzheimer's Disease, Front.
Aging Neurosci.
Leave a message here
